Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease

NCT01291641 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

342

Enrollment

OTHER

Sponsor class

Conditions

Hyperlipidemias

Interventions

DRUG: HMG-CoA Reductase Inhibitor
DRUG: Probucol
DRUG: Cilostazol

Sponsor

Seoul National University Hospital

Collaborators

[object Object]